BIOMAT Database Logo BIOMAT Database Logo

A study of renal transplants obtained from anti-HCV positive donors. 1991

E Gómez, and S Aguado, and E Gago, and A Martinez, and R Cimadevilla, and S Melón, and M de Oña, and J Alvarez-Grande
Department of Nephrology, Hospital Covadonga, Oviedo, Spain.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

E Gómez, and S Aguado, and E Gago, and A Martinez, and R Cimadevilla, and S Melón, and M de Oña, and J Alvarez-Grande
Kidney transplantation from anti-HCV-positive donors to anti-HCV-positive recipients.
June 1993, Transplantation proceedings,
E Gómez, and S Aguado, and E Gago, and A Martinez, and R Cimadevilla, and S Melón, and M de Oña, and J Alvarez-Grande
Use of kidneys from anti-HCV positive donors.
January 2001, Transplantation proceedings,
E Gómez, and S Aguado, and E Gago, and A Martinez, and R Cimadevilla, and S Melón, and M de Oña, and J Alvarez-Grande
Transplantation of kidneys from Anti-HCV positive donors.
January 2001, Transplantation proceedings,
E Gómez, and S Aguado, and E Gago, and A Martinez, and R Cimadevilla, and S Melón, and M de Oña, and J Alvarez-Grande
Dilemmas of organ transplantation from anti-HCV-positive donors.
February 1995, Lancet (London, England),
E Gómez, and S Aguado, and E Gago, and A Martinez, and R Cimadevilla, and S Melón, and M de Oña, and J Alvarez-Grande
Current status of renal transplantation from HCV-positive donors.
May 2009, The International journal of artificial organs,
E Gómez, and S Aguado, and E Gago, and A Martinez, and R Cimadevilla, and S Melón, and M de Oña, and J Alvarez-Grande
Heart and Lung Transplants from HCV-Infected Donors.
September 2019, The New England journal of medicine,
E Gómez, and S Aguado, and E Gago, and A Martinez, and R Cimadevilla, and S Melón, and M de Oña, and J Alvarez-Grande
Heart and Lung Transplants from HCV-Infected Donors.
September 2019, The New England journal of medicine,
E Gómez, and S Aguado, and E Gago, and A Martinez, and R Cimadevilla, and S Melón, and M de Oña, and J Alvarez-Grande
Heart and Lung Transplants from HCV-Infected Donors.
September 2019, The New England journal of medicine,
E Gómez, and S Aguado, and E Gago, and A Martinez, and R Cimadevilla, and S Melón, and M de Oña, and J Alvarez-Grande
[Renal transplants from anencephalic donors].
December 1989, Boletin medico del Hospital Infantil de Mexico,
E Gómez, and S Aguado, and E Gago, and A Martinez, and R Cimadevilla, and S Melón, and M de Oña, and J Alvarez-Grande
Product lookback for anti-HCV-positive blood donors.
January 1995, Vox sanguinis,
Copied contents to your clipboard!